GoodRx (NASDAQ:GDRX) Shares Up 5.8% – What’s Next?

Shares of GoodRx Holdings, Inc. (NASDAQ:GDRX) shot up 5.8% during trading on Friday . The company traded as high as $4.54 and last traded at $4.53. 660,285 shares changed hands during mid-day trading, a decline of 39% from the average session volume of 1,087,214 shares. The stock had previously closed at $4.28.

Analyst Ratings Changes

GDRX has been the subject of several recent research reports. KeyCorp reduced their price target on GoodRx from $7.00 to $6.00 and set an “overweight” rating for the company in a research report on Wednesday. Citigroup cut their price objective on shares of GoodRx from $10.00 to $7.00 and set a “buy” rating for the company in a research report on Wednesday, November 13th. Morgan Stanley reduced their target price on shares of GoodRx from $7.00 to $6.00 and set an “equal weight” rating for the company in a research report on Tuesday, December 17th. Barclays lowered their price objective on GoodRx from $10.00 to $6.00 and set an “overweight” rating on the stock in a research note on Monday, November 11th. Finally, Mizuho began coverage on shares of GoodRx in a report on Wednesday, December 4th. They set a “neutral” rating and a $5.00 price target for the company. Five equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $8.43.

GoodRx Stock Up 4.0 %

The company has a market cap of $1.70 billion, a P/E ratio of -148.33, a P/E/G ratio of 3.43 and a beta of 1.27. The company’s 50-day moving average is $4.75 and its two-hundred day moving average is $6.59. The company has a debt-to-equity ratio of 0.70, a current ratio of 5.48 and a quick ratio of 5.48.

Institutional Trading of GoodRx

A number of institutional investors have recently made changes to their positions in the stock. Cornercap Investment Counsel Inc. boosted its position in GoodRx by 1.7% in the second quarter. Cornercap Investment Counsel Inc. now owns 75,269 shares of the company’s stock worth $587,000 after purchasing an additional 1,266 shares during the last quarter. nVerses Capital LLC bought a new stake in GoodRx during the 3rd quarter worth approximately $33,000. Plato Investment Management Ltd bought a new position in shares of GoodRx in the second quarter worth approximately $43,000. Fortem Financial Group LLC boosted its position in shares of GoodRx by 7.2% in the fourth quarter. Fortem Financial Group LLC now owns 119,179 shares of the company’s stock worth $554,000 after purchasing an additional 7,996 shares during the period. Finally, XTX Topco Ltd raised its position in shares of GoodRx by 42.4% during the 2nd quarter. XTX Topco Ltd now owns 29,560 shares of the company’s stock valued at $231,000 after purchasing an additional 8,801 shares during the period. Hedge funds and other institutional investors own 63.77% of the company’s stock.

GoodRx Company Profile

GoodRx Holdings, Inc, together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices.